HINJ joined MDMA, AdvaMed, MITA and a broad coalition of medical innovators, physician inventors, patient groups in sending a letter to Congress Sept. 24 urging them to permanently repeal the medical device excise tax to the innovation ecosystem. While the tax was in place from 2013 through 2015, thousands of good paying jobs were lost, research and development projects were abandoned and patients were denied new treatments. The Senate and House have both previously passed repeal legislation with strong bipartisan majorities, and now is the time to put an end to this punishing policy before the current suspension expires on Dec. 31, 2019. The letter is posted here.
Menu